Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy
NCT ID: NCT05110573
Last Updated: 2021-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
172 participants
OBSERVATIONAL
2000-01-01
2021-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a retrospective comparison of a prospectively kept database. The investigators compared surgical outcomes and survival after laparoscopic (LPD) versus open pancreatoduodenectomy (OPD). In order to reduce the effect of bias and confounding, baseline characteristics of both groups were matched using propensity score matching.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary endpoint was the major complication rate, defined by a Clavien-Dindo morbidity classification grade IIIa or higher \[11\]. Secondary endpoints were 90-day mortality rate, length of hospital stay, operative time, blood loss, transfusion requirements and specific pancreatic complications (pancreatic fistula, haemorrhage, and delayed gastric emptying). In addition, overall survival (OS) and disease-free survival (DFS) were analysed in the subgroups of cancer patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laparoscopic pancreatoduodenectomy
Cohort of patients that underwent a Whipple-procedure through a laparoscopic approach.
pancreatoduodenectomy
Patients included in the cohorts all underwent pancreatoduodenectomy, open or laparoscopic
Open pancreatoduodenectomy
Cohort of patients that underwent a Whipple-procedure through a traditional open approach.
pancreatoduodenectomy
Patients included in the cohorts all underwent pancreatoduodenectomy, open or laparoscopic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pancreatoduodenectomy
Patients included in the cohorts all underwent pancreatoduodenectomy, open or laparoscopic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Hospital Groeninge
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. M. D'hondt
Dr. Mathieu D'Hondt, Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mathieu D'Hondt, MD
Role: PRINCIPAL_INVESTIGATOR
1. Department of Digestive and Hepatobiliary/Pancreatic Surgery AZ Groeninge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Hospital Groeninge
Kortrijk, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vandeputte M, Vansteenkiste F, Ceelen W, De Meyere C, D'Hondt M. Morbidity and survival after laparoscopic versus open pancreatoduodenectomy: propensity score matched comparison. Langenbecks Arch Surg. 2023 Jan 10;408(1):16. doi: 10.1007/s00423-023-02758-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B3962020000032
Identifier Type: -
Identifier Source: org_study_id